$HDSN
HUDSON TECHNOLOGIES INC /NY

2023 Q3 Form 10-Q Financial Statement

#000141057823001590 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $76.50M $90.47M
YoY Change -14.53% -12.96%
Cost Of Revenue $45.92M $53.85M
YoY Change 1.44% 15.94%
Gross Profit $30.58M $36.63M
YoY Change -30.88% -36.3%
Gross Profit Margin 39.98% 40.48%
Selling, General & Admin $6.760M $8.273M
YoY Change -6.36% 17.95%
% of Gross Profit 22.11% 22.59%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.410M $699.0K
YoY Change 102.01% -53.02%
% of Gross Profit 4.61% 1.91%
Operating Expenses $7.458M $8.972M
YoY Change -5.8% 16.32%
Operating Profit $23.12M $27.66M
YoY Change -36.34% -44.45%
Interest Expense $4.358M -$1.899M
YoY Change -284.27% -172.4%
% of Operating Profit 18.85% -6.87%
Other Income/Expense, Net -$4.358M
YoY Change
Pretax Income $18.76M $25.76M
YoY Change -44.74% -45.39%
Income Tax $5.182M $6.567M
% Of Pretax Income 27.62% 25.5%
Net Earnings $13.58M $19.19M
YoY Change -53.73% -51.8%
Net Earnings / Revenue 17.76% 21.21%
Basic Earnings Per Share $0.30 $0.42
Diluted Earnings Per Share $0.29 $0.41
COMMON SHARES
Basic Shares Outstanding 45.40M 45.33M
Diluted Shares Outstanding 47.35M 47.30M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.800M $11.42M
YoY Change -74.75% -44.81%
Cash & Equivalents $3.783M $11.42M
Short-Term Investments
Other Short-Term Assets $10.10M $10.38M
YoY Change -46.11% 44.02%
Inventory $139.2M $134.4M
Prepaid Expenses
Receivables $44.94M $49.06M
Other Receivables $0.00 $0.00
Total Short-Term Assets $198.1M $205.3M
YoY Change 2.84% 7.88%
LONG-TERM ASSETS
Property, Plant & Equipment $20.57M $27.41M
YoY Change -24.12% 42.84%
Goodwill $47.80M $47.80M
YoY Change 0.0%
Intangibles $15.47M $16.17M
YoY Change -14.73%
Long-Term Investments
YoY Change
Other Assets $2.418M $2.386M
YoY Change 217.32% 245.8%
Total Long-Term Assets $93.30M $93.76M
YoY Change -0.67% -0.71%
TOTAL ASSETS
Total Short-Term Assets $198.1M $205.3M
Total Long-Term Assets $93.30M $93.76M
Total Assets $291.4M $299.1M
YoY Change 1.69% 5.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.80M $17.58M
YoY Change 12.83% 26.68%
Accrued Expenses $35.30M $31.76M
YoY Change -11.6% -17.76%
Deferred Revenue
YoY Change
Short-Term Debt $5.000M $0.00
YoY Change
Long-Term Debt Due $5.000M $4.250M
YoY Change 17.65% 0.0%
Total Short-Term Liabilities $57.12M $53.59M
YoY Change -3.31% -5.56%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $25.09M
YoY Change -100.0% -68.91%
Other Long-Term Liabilities $5.200M $5.773M
YoY Change -15.83% -8.12%
Total Long-Term Liabilities $5.200M $30.86M
YoY Change -90.72% -61.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $57.12M $53.59M
Total Long-Term Liabilities $5.200M $30.86M
Total Liabilities $66.81M $87.61M
YoY Change -42.39% -39.08%
SHAREHOLDERS EQUITY
Retained Earnings $106.3M $92.70M
YoY Change 293.73%
Common Stock $455.0K $454.0K
YoY Change 0.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $224.6M $211.5M
YoY Change
Total Liabilities & Shareholders Equity $291.4M $299.1M
YoY Change 1.69% 5.03%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $13.58M $19.19M
YoY Change -53.73% -51.8%
Depreciation, Depletion And Amortization $1.410M $699.0K
YoY Change 102.01% -53.02%
Cash From Operating Activities $22.27M $10.58M
YoY Change -14.83% -63.27%
INVESTING ACTIVITIES
Capital Expenditures $1.380M $425.0K
YoY Change -254.19% -153.59%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.380M -$425.0K
YoY Change 54.19% -46.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -28.53M -11.06M
YoY Change -7.63% -11.35%
NET CHANGE
Cash From Operating Activities 22.27M 10.58M
Cash From Investing Activities -1.380M -425.0K
Cash From Financing Activities -28.53M -11.06M
Net Change In Cash -7.640M -907.0K
YoY Change 35.63% -105.84%
FREE CASH FLOW
Cash From Operating Activities $22.27M $10.58M
Capital Expenditures $1.380M $425.0K
Free Cash Flow $20.89M $10.15M
YoY Change -22.76% -65.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0000925528
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
HUDSON TECHNOLOGIES INC /NY
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45375598
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45287619
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M16D
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-13412
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3641539
dei Entity Address Address Line1
EntityAddressAddressLine1
300 Tice Boulevard
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 290
dei Entity Address City Or Town
EntityAddressCityOrTown
Woodcliff Lake
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07677
dei City Area Code
CityAreaCode
845
dei Local Phone Number
LocalPhoneNumber
735-6000
dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
dei Trading Symbol
TradingSymbol
HDSN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45395085
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11415000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5295000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
49057000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20872000
CY2023Q2 us-gaap Inventory Net
InventoryNet
134444000
CY2022Q4 us-gaap Inventory Net
InventoryNet
145377000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10377000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5289000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
205293000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
176833000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19909000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20568000
CY2023Q2 us-gaap Goodwill
Goodwill
47803000
CY2022Q4 us-gaap Goodwill
Goodwill
47803000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16167000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17564000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7497000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7339000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2386000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2386000
CY2023Q2 us-gaap Assets
Assets
299055000
CY2022Q4 us-gaap Assets
Assets
272493000
CY2023Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
17579000
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
14165000
CY2023Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
28334000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
27908000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3423000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6303000
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
4250000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4250000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
53586000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
52626000
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3161000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
244000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5773000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5763000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25085000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
38985000
CY2023Q2 us-gaap Liabilities
Liabilities
87605000
CY2022Q4 us-gaap Liabilities
Liabilities
97618000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45375598
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45287619
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
454000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
453000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
118296000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
116442000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
92700000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
57980000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
211450000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
174875000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
299055000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
272493000
CY2023Q2 us-gaap Revenues
Revenues
90474000
CY2022Q2 us-gaap Revenues
Revenues
103941000
us-gaap Revenues
Revenues
167673000
us-gaap Revenues
Revenues
188279000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
53847000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
46444000
us-gaap Cost Of Revenue
CostOfRevenue
100716000
us-gaap Cost Of Revenue
CostOfRevenue
84962000
CY2023Q2 us-gaap Gross Profit
GrossProfit
36627000
CY2022Q2 us-gaap Gross Profit
GrossProfit
57497000
us-gaap Gross Profit
GrossProfit
66957000
us-gaap Gross Profit
GrossProfit
103317000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8273000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7014000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15250000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13838000
CY2023Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
699000
CY2022Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
699000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1397000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1397000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
8972000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
7713000
us-gaap Operating Expenses
OperatingExpenses
16647000
us-gaap Operating Expenses
OperatingExpenses
15235000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
27655000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
49784000
us-gaap Operating Income Loss
OperatingIncomeLoss
50310000
us-gaap Operating Income Loss
OperatingIncomeLoss
88082000
CY2023Q2 us-gaap Interest Expense
InterestExpense
1899000
CY2022Q2 us-gaap Interest Expense
InterestExpense
2623000
us-gaap Interest Expense
InterestExpense
3748000
us-gaap Interest Expense
InterestExpense
9928000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
25756000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
47161000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
46562000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
78154000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6567000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7351000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11842000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8789000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
19189000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
39810000
us-gaap Net Income Loss
NetIncomeLoss
34720000
us-gaap Net Income Loss
NetIncomeLoss
69365000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.89
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.77
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.55
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.84
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.48
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45339570
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44960464
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45319155
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44870642
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47297419
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47152257
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47305196
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46974441
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
100896000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
52000
CY2022Q2 hdsn Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
1000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
180000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
39810000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
140937000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
191499000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000
CY2023Q2 hdsn Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
1000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
762000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
19189000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
211450000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
70939000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
123000
hdsn Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
73000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
583000
us-gaap Profit Loss
ProfitLoss
69365000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
140937000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
174875000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
39000
hdsn Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
3000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1819000
us-gaap Profit Loss
ProfitLoss
34720000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
211450000
us-gaap Net Income Loss
NetIncomeLoss
34720000
us-gaap Net Income Loss
NetIncomeLoss
69365000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1495000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1726000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1397000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1397000
us-gaap Inventory Write Down
InventoryWriteDown
-1104000
us-gaap Inventory Write Down
InventoryWriteDown
-1155000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
851000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1207000
us-gaap Share Based Compensation
ShareBasedCompensation
1819000
us-gaap Share Based Compensation
ShareBasedCompensation
583000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
538000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2004000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4665000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2917000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1602000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
29037000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30727000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-12037000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
23366000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5200000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1677000
hdsn Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
2000
hdsn Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
15000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
1741000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2552000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8078000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21246000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33867000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
837000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
820000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-837000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-820000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
39000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
123000
hdsn Excess Tax Benefits From Share Based Compensation Financing Activities
ExcessTaxBenefitsFromShareBasedCompensationFinancingActivities
-3000
hdsn Excess Tax Benefits From Share Based Compensation Financing Activities
ExcessTaxBenefitsFromShareBasedCompensationFinancingActivities
-73000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
8512000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-15000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
100000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
14325000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
92395000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-14289000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15857000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
6120000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
17190000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5295000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3492000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11415000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20682000
us-gaap Interest Paid Net
InterestPaidNet
2952000
us-gaap Interest Paid Net
InterestPaidNet
7911000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10665000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5908000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
hdsn Percentage Of Stepdown From Baseline Levels Final Rule
PercentageOfStepdownFromBaselineLevelsFinalRule
0.10
hdsn Percentage Of Cumulative Reduction From Baseline Levels Subsequent Allowance
PercentageOfCumulativeReductionFromBaselineLevelsSubsequentAllowance
0.40
hdsn Allocation Allowance Received
AllocationAllowanceReceived
3000000
hdsn Allocation Allowance Received By Company As Percentage Of Hydrofluorocarbons Consumption
AllocationAllowanceReceivedByCompanyAsPercentageOfHydrofluorocarbonsConsumption
0.01
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of temporary cash investments and trade accounts receivable. The Company maintains its temporary cash investments in highly-rated financial institutions and, at times, the balances exceed FDIC insurance coverage. The Company’s trade accounts receivable are primarily due from companies throughout the United States. The Company reviews each customer’s credit history before extending credit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company establishes an allowance for doubtful accounts based on factors associated with the credit risk of specific accounts, historical trends, and other information. The carrying value of the Company’s accounts receivable is reduced by the established allowance for doubtful accounts. The allowance for doubtful accounts includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve for the remaining accounts receivable balances. The Company adjusts its reserves based on factors that affect the collectability of the accounts receivable balances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For the six month period ended June 30, 2023 there was one customer accounting for greater than 10% of the Company’s revenues and at June 30, 2023 there were $14.6 million of accounts receivable from this customer. For the six-month period ended June 30, 2022 there was no customer accounting for 10% of the Company’s revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company’s products or services by any such customer could have a material adverse effect on the Company’s operating results and financial position.</p>
us-gaap Depreciation
Depreciation
1700000
CY2023Q1 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q2 hdsn Cylinder Deposit Value
CylinderDepositValue
15900000
CY2022Q4 hdsn Cylinder Deposit Value
CylinderDepositValue
13600000
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15100000
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11600000
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3500000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3500000
CY2023Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1800000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
19189000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
39810000
us-gaap Net Income Loss
NetIncomeLoss
34720000
us-gaap Net Income Loss
NetIncomeLoss
69365000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45339570
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44960464
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45319155
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44870642
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1957849
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2191793
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1986041
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2103799
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47297419
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47152257
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47305196
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46974441
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
602321
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
752
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
499857
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1090
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Estimates and Risks</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires the use of estimates and assumptions that affect the amounts reported in these financial statements and footnotes. The Company considers these accounting estimates to be critical in the preparation of the accompanying consolidated financial statements. The Company uses information available at the time the estimates are made. However, these estimates could change materially if different information or assumptions were used. Additionally, these estimates may not ultimately reflect the actual amounts of the final transactions that occur. The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Several of the Company’s accounting policies involve significant judgments, uncertainties, and estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management’s judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for doubtful accounts, inventory reserves, goodwill and commitments and contingencies. With respect to trade accounts receivable, the Company estimates the necessary allowance for doubtful accounts based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company participates in an industry that is highly regulated, and changes in the regulations affecting its business could affect its operating results. Currently the Company purchases virgin hydrofluorocarbon (“HFC”) and hydrofluroolefin (‘HFO”) refrigerants and reclaimable, primarily hydrochlorofluorocarbons (“HCFC”), HFC and chlorofluorocarbon (“CFC”), refrigerants from suppliers and its customers. To the extent that the Company is unable to source sufficient quantities of refrigerants or is unable to obtain refrigerants on commercially reasonable terms or experiences a decline in demand and/or price for refrigerants sold by the Company, the Company could realize reductions in revenue from refrigerant sales, which could have a material adverse effect on its operating results and its financial position. The process of sourcing refrigerants includes various procurement costs, such as freight, processing, insurance, and other costs, relating to the delivery of refrigerants. As a result of the recently noted global supply chain issues, the Company determined it could be exposed to incremental costs related to these refrigerant purchases. These costs represent the Company’s initial estimate that are possibly subject to finalization in future periods and are recorded in accrued expenses and other current liabilities on the consolidated balance sheet as of June 30, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company is subject to various legal proceedings. The Company assesses the merit and potential liability associated with each of these proceedings. In addition, the Company estimates potential liability, if any, related to these matters. To the extent that these estimates are not accurate, or circumstances change in the future, the Company could realize liabilities, which could have a material adverse effect on its operating results and its financial position.</p>
us-gaap Depreciation
Depreciation
1500000
CY2023Q2 us-gaap Inventory Gross
InventoryGross
140631000
CY2022Q4 us-gaap Inventory Gross
InventoryGross
152840000
CY2023Q2 us-gaap Inventory Adjustments
InventoryAdjustments
6187000
CY2022Q4 us-gaap Inventory Adjustments
InventoryAdjustments
7463000
CY2023Q2 us-gaap Inventory Net
InventoryNet
134444000
CY2022Q4 us-gaap Inventory Net
InventoryNet
145377000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58205000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57405000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
38296000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
36837000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19909000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20568000
CY2023Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1597000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2372000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1994000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1374000
CY2023Q2 hdsn Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
1929000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9266000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1684000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
7582000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1809000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5773000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
7582000
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0822
us-gaap Operating Lease Payments
OperatingLeasePayments
1300000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q2 us-gaap Goodwill
Goodwill
47800000
CY2022Q4 us-gaap Goodwill
Goodwill
47800000
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
32997000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16830000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16167000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
32997000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15433000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17564000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1400000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1400000
CY2023Q2 us-gaap Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
4227261
CY2023Q2 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Non Vested
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonVested
1.10
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2667043
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y7M17D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.56
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
18700000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
20600000
CY2023Q2 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Nonvested.
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonvested.
0.0
CY2023Q2 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Nonvested.
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonvested.
0.0
CY2022Q4 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Nonvested.
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonvested.
1100000
CY2022Q4 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Nonvested.
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonvested.
1100000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
400000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1800000
CY2023Q2 hdsn Long Term Debt Current Net Of Other Debt.
LongTermDebtCurrentNetOfOtherDebt.
4250000
CY2022Q4 hdsn Long Term Debt Current Net Of Other Debt.
LongTermDebtCurrentNetOfOtherDebt.
4250000
CY2023Q2 us-gaap Debt Current
DebtCurrent
4250000
CY2022Q4 us-gaap Debt Current
DebtCurrent
4250000
CY2023Q2 hdsn Long Term Debt Non Current Net Of Other Debt
LongTermDebtNonCurrentNetOfOtherDebt
13238000
CY2022Q4 hdsn Long Term Debt Non Current Net Of Other Debt
LongTermDebtNonCurrentNetOfOtherDebt
27563000
CY2023Q2 hdsn Long Term Debt First In Last Out Filo
LongTermDebtFirstInLastOutFilo
15000000
CY2022Q4 hdsn Long Term Debt First In Last Out Filo
LongTermDebtFirstInLastOutFilo
15000000
CY2023Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3153000
CY2022Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3578000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25085000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
38985000
CY2023Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
29335000
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
43235000
CY2022Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
90000000
CY2022Q1 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.020
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
4250000
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
4250000
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
4250000
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
19738000
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
32488000
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001410578-23-001590-index-headers.html Edgar Link pending
0001410578-23-001590-index.html Edgar Link pending
0001410578-23-001590.txt Edgar Link pending
0001410578-23-001590-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hdsn-20230630.xsd Edgar Link pending
hdsn-20230630x10q.htm Edgar Link pending
hdsn-20230630xex31d1.htm Edgar Link pending
hdsn-20230630xex31d2.htm Edgar Link pending
hdsn-20230630xex32d1.htm Edgar Link pending
hdsn-20230630xex32d2.htm Edgar Link pending
hdsn-20230630x10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
hdsn-20230630_def.xml Edgar Link unprocessable
hdsn-20230630_lab.xml Edgar Link unprocessable
hdsn-20230630_pre.xml Edgar Link unprocessable
hdsn-20230630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable